# GRI Bio, Inc.: filings

GRI · Nasdaq · CIK 1824293 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gri.md) · [Financials](/companies/gri/financials.md) · [Filings](/companies/gri/filings.md) · [Insiders](/companies/gri/insiders.md)

## Reports and events: 156 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 99, 4 53, 424B3 33, CORRESP 28, 10-Q 17, UPLOAD 17, 3 15, EFFECT 13, DEFA14A 11, DEF 14A 10, S-1/A 10, 424B5 9, SC 13G 7, 10-K 6, PRE 14A 6, S-1 6, S-3 6, 424B4 5, 425 4, ARS 4, S-4/A 4, S-8 4, SC 13D 4, SC 13G/A 4, SCHEDULE 13G/A 4, 8-K/A 3, DRS 3, SCHEDULE 13G 3, D 2, SEC STAFF LETTER 2, 8-A12B 1, CERT 1, DRSLTR 1, FWP 1, S-1MEF 1, S-4 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 16:43 ET | [DEF 14A](/filings/0001824293-26-000060.md) | Proxy statement, period 2026-11-04 | 0001824293-26-000060 |
| 2026-09-08 | 08:16 ET | [8-K](/filings/0001824293-26-000057.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000057 |
| 2026-08-14 | 07:44 ET | [10-Q](/filings/0001824293-26-000055.md) | Quarterly report, period 2026-06-30 | 0001824293-26-000055 |
| 2026-06-18 | 16:50 ET | [8-K](/filings/0001824293-26-000050.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000050 |
| 2026-05-14 | 08:36 ET | [8-K](/filings/0001824293-26-000046.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000046 |
| 2026-05-13 | 16:16 ET | [10-Q](/filings/0001824293-26-000044.md) | Quarterly report, period 2026-03-31 | 0001824293-26-000044 |
| 2026-02-04 | 08:48 ET | [8-K](/filings/0001824293-26-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001824293-26-000040 |
| 2026-01-30 | 07:34 ET | [10-K](/filings/0001824293-26-000033.md) | Annual report, period 2025-12-31 | 0001824293-26-000033 |
| 2026-01-30 | 20:22 ET | [8-K](/filings/0001824293-26-000030.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001824293-26-000030 |
| 2026-01-28 | 08:46 ET | [8-K](/filings/0001824293-26-000017.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000017 |
| 2026-01-21 | 16:10 ET | [8-K](/filings/0001824293-26-000014.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000014 |
| 2026-01-16 | 08:00 ET | [8-K](/filings/0001824293-26-000011.md) | 3.01 Delisting notice | 0001824293-26-000011 |
| 2026-01-15 | 10:15 ET | [8-K](/filings/0001824293-26-000009.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001824293-26-000009 |
| 2026-01-09 | 08:31 ET | [8-K](/filings/0001824293-26-000006.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000006 |
| 2026-01-08 | 08:01 ET | [8-K](/filings/0001824293-26-000002.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000002 |
| 2025-12-29 | 08:08 ET | [DEF 14A](/filings/0001824293-25-000173.md) | Proxy statement, period 2026-01-15 | 0001824293-25-000173 |
| 2025-12-12 | 16:05 ET | [8-K](/filings/0001628280-25-056751.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-056751 |
| 2025-12-12 | 08:30 ET | [8-K](/filings/0001628280-25-056659.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-056659 |
| 2025-12-10 | 16:05 ET | [8-K](/filings/0001824293-25-000167.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-25-000167 |
| 2025-12-10 | 21:11 ET | [S-1/A](/filings/0001628280-25-056215.md) | Registration statement, amended | 0001628280-25-056215 |
| 2025-12-08 | 08:19 ET | [S-1](/filings/0001628280-25-055716.md) | Registration statement | 0001628280-25-055716 |
| 2025-12-08 | 08:00 ET | [8-K](/filings/0001824293-25-000160.md) | 8.01 Other events | 0001824293-25-000160 |
| 2025-12-02 | 08:00 ET | [8-K](/filings/0001824293-25-000155.md) | 3.01 Delisting notice | 0001824293-25-000155 |
| 2025-11-14 | 07:45 ET | [10-Q](/filings/0001824293-25-000151.md) | Quarterly report, period 2025-09-30 | 0001824293-25-000151 |
| 2025-08-20 | 09:28 ET | [8-K](/filings/0001824293-25-000126.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001824293-25-000126 |
| 2025-08-14 | 06:57 ET | [10-Q](/filings/0001824293-25-000106.md) | Quarterly report, period 2025-06-30 | 0001824293-25-000106 |
| 2025-08-13 | 16:16 ET | [8-K](/filings/0001824293-25-000096.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001824293-25-000096 |
| 2025-07-31 | 09:02 ET | [8-K](/filings/0001824293-25-000094.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-25-000094 |
| 2025-07-11 | 16:17 ET | [DEF 14A](/filings/0001824293-25-000089.md) | Proxy statement, period 2025-08-13 | 0001824293-25-000089 |
| 2025-06-26 | 08:01 ET | [8-K](/filings/0001824293-25-000082.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001824293-25-000082 |
| 2025-05-23 | 07:16 ET | [8-K](/filings/0001824293-25-000079.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-25-000079 |
| 2025-05-15 | 08:38 ET | [10-Q](/filings/0001824293-25-000073.md) | Quarterly report, period 2025-03-31 | 0001824293-25-000073 |
| 2025-05-15 | 08:35 ET | [8-K](/filings/0001824293-25-000072.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001824293-25-000072 |
| 2025-05-05 | 07:35 ET | [8-K](/filings/0001824293-25-000063.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-25-000063 |
| 2025-04-16 | 18:14 ET | [8-K](/filings/0001824293-25-000058.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001824293-25-000058 |
| 2025-04-02 | 08:29 ET | [8-K](/filings/0001628280-25-016066.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-016066 |
| 2025-03-26 | 15:11 ET | [S-1/A](/filings/0001628280-25-014928.md) | Registration statement, amended | 0001628280-25-014928 |
| 2025-03-25 | 06:21 ET | [S-1](/filings/0001628280-25-014582.md) | Registration statement | 0001628280-25-014582 |
| 2025-03-17 | 08:06 ET | [8-K](/filings/0001824293-25-000053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001824293-25-000053 |
| 2025-03-14 | 17:00 ET | [10-K](/filings/0001824293-25-000050.md) | Annual report, period 2024-12-31 | 0001824293-25-000050 |
| 2025-03-11 | 08:37 ET | [8-K](/filings/0001824293-25-000045.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-25-000045 |
| 2025-02-19 | 16:08 ET | [8-K](/filings/0001824293-25-000042.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-25-000042 |
| 2025-02-11 | 16:05 ET | [8-K](/filings/0001824293-25-000039.md) | 5.07 Shareholder vote results | 0001824293-25-000039 |
| 2025-01-17 | 16:05 ET | [DEF 14A](/filings/0001824293-25-000011.md) | Proxy statement, period 2025-02-11 | 0001824293-25-000011 |
| 2024-12-20 | 16:05 ET | [8-K](/filings/0001824293-24-000159.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-24-000159 |
| 2024-11-14 | 16:24 ET | [8-K](/filings/0001824293-24-000153.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001824293-24-000153 |
| 2024-11-14 | 16:16 ET | [10-Q](/filings/0001824293-24-000151.md) | Quarterly report, period 2024-09-30 | 0001824293-24-000151 |
| 2024-10-24 | 08:35 ET | [8-K](/filings/0001824293-24-000143.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-24-000143 |
| 2024-10-22 | 16:21 ET | [8-K](/filings/0001824293-24-000141.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-24-000141 |
| 2024-09-11 | 16:36 ET | [8-K/A](/filings/0001824293-24-000138.md) | 3.01 Delisting notice | 0001824293-24-000138 |

Page 1 of 4. [Older](/companies/gri/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.